Biotech

All Articles

ArsenalBio increases $325M, rotates off of previous lead resource

.Toolbox Biosciences is actually proceeding up. The cell therapy business has added $325 thousand in...

Lilly- supported weight-loss biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' cannabis make use of medication fails period 2b, driving Indivior to reassess $100M possibility

.Aelis Farma's hopes of securing a fast, good choice on a $one hundred thousand option settlement ha...

ProKidney stops phase 3 test certainly not required for tissue therapy permission

.ProKidney has actually ceased some of a pair of stage 3 tests for its cell treatment for renal cond...

Vaxcyte surges on 'remarkable' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what experts referred to as "sensational" stage 1/2 information for its own 31-val...

Recursion's human brain health condition trial presents scant proof of effectiveness

.Recursion has actually stumbled by means of an early test of its tech-enabled technique to drug dis...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Phone it a case of good chemistry: Acepodia, a biotech based on Nobel Champion scientific research,...

Praxis epilepsy medication reduces confiscations in period 2 hearing

.Praxis Preciseness Medicines has actually scored another midphase succeed in epilepsy this year, wi...

Three officers surrender as Dyne articles mixed data for DMD candidate

.After running away a professional grip many years back, Dyne Rehab has actually exposed brand new p...

Arrowhead fires off phase 3 information in rare metabolic ailment before market encounter Ionis

.Arrowhead Pharmaceuticals has presented its give before a possible face-off along with Ionis, publi...